Good News For Wockhardt, Sputnik Vaccine Is Ready For Production And Export

Sputnik vaccine is ready for production and export. Wockhardt got approval from CDSCO to export 10 crore dose. Income up to ₹ 2000 crore is possible from vaccine export. Wockhardt tied up with SII for vaccine production in UK plant. The agreement with AstraZeneca is expected to extend for a few years. Why Wockhardt is in focus, know full details from Kushal Gupta.

Updated on: December 22, 2022, 10.07 AM IST
ZEEBIZ TRENDING STORIES